Abbott's landmark LIFE-BTK randomized clinical trial met its primary safety and effectiveness endpoints, demonstrating that Esprit BTK offers significant advancements in opening and keeping blocked arteries below-the-knee open compared to the standard of care, balloon angioplasty
Program planners for TCT 2023 recently discussed highly-anticipated sessions, including a MedTech Innovation Forum and FDA Town Hall, to take place during the Cardiovascular Research Foundation's (CRF) annual scientific symposium. Its Transcatheter Cardiovascular Therapeutics (TCT) conference, TCT 2023, will take place from October 23-26 at the Moscone Center in San Francisco, CA.